Track-and-trace added to compounding bill; Boehringer Ingelheim expands in China;

@EricPFierce: Kashmir-born Ph.D. picked by FDA to head office in India where problems mount. Story | Follow @EricPFierce

> House and Senate committees working on legislation to regulate the largest compounding pharmacies are also planning to drop into the bill track-and-trace rules that have been in negotiation. Story

> Boehringer Ingelheim says it will expand a plant in China. Report

> W.S. Badger is voluntarily recalling all lots of its 4-ounce SPF 30 Baby Sunscreen Lotion and one lot of its 4-ounce SPF 30 Kids Sunscreen Lotion after testing discovered they were contaminated with Pseudomonas aeruginosa, Candida parapsilosis and Acremonium fungi. Release

> Pfizer ($PFE), GEA and G-CON say they have created a joint venture called PCMM (portable continuous miniature & modular), which will work to build a platform to bring more flexibility to plants with fixed equipment. Report

> The FDA is closing an office in Jordan but says it will not hinder plant inspections in the region. Report

And Finally... A survey from a group advocating new regulations for compounding pharmacies, says that regulation of the industry is favored by 73% of Republicans, 83% of Democrats and 70% of independents. Report